Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis
暂无分享,去创建一个
T. Masaki | T. Takayama | J. Tani | K. Uchida | H. Miyamoto | K. Okamoto | N. Muguruma | A. Hirose | M. Sogabe | Hironori Tanaka | Tetsu Tomonari | Tatsuya Taniguchi | A. Morishita | Takahiro Tanaka | C. Ogawa | Y. Sato